Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1977 1
1979 1
1980 1
1988 1
1994 1
1999 1
2001 1
2003 1
2005 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Pearson syndrome.
Farruggia P, Di Marco F, Dufour C. Farruggia P, et al. Expert Rev Hematol. 2018 Mar;11(3):239-246. doi: 10.1080/17474086.2018.1426454. Epub 2018 Jan 23. Expert Rev Hematol. 2018. PMID: 29337599 Review.
Clinical phenotype is extremely variable and may change over the course of disease itself with the possibility both of worsenings and improvements. ...
Clinical phenotype is extremely variable and may change over the course of disease itself with the possibility both of worsenings and …
Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.
Cheng DS, Kushner JP, Wintrobe MM. Cheng DS, et al. Cancer. 1979 Aug;44(2):724-31. doi: 10.1002/1097-0142(197908)44:2<724::aid-cncr2820440245>3.0.co;2-w. Cancer. 1979. PMID: 383260 Review.
The clinical course of 29 patients with idiopathic refractory sideroblastic anemia studied by us was reviewed. ...The patients who died of acute leukemia tended to have a more severe anemia, a lower reticulocyte count, and increased transfusion requirement, and thrombocyto …
The clinical course of 29 patients with idiopathic refractory sideroblastic anemia studied by us was reviewed. ...The patients who di …
Natural history of idiopathic refractory sideroblastic anemia.
Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E. Cazzola M, et al. Blood. 1988 Feb;71(2):305-12. Blood. 1988. PMID: 3337899 Free article.
The median survival was 72 months, with a high transfusion requirement, multilineage defects, and inappropriately low erythroid proliferation being associated with a poor prognosis. The most common causes of death were complications of iron overload and evolution into ANLL …
The median survival was 72 months, with a high transfusion requirement, multilineage defects, and inappropriately low erythroid proliferatio …
Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases.
Ramos-Casals M, García-Carrasco M, López-Medrano F, Trejo O, Forns X, López-Guillermo A, Muñoz C, Ingelmo M, Font J. Ramos-Casals M, et al. Medicine (Baltimore). 2003 Mar;82(2):87-96. doi: 10.1097/00005792-200303000-00003. Medicine (Baltimore). 2003. PMID: 12640185 Free article. Review.
Patients with HCV-related AHA showed a higher prevalence of associated autoimmune diseases (71%), cryoglobulins (67%), and cirrhosis (59%). All had a good response to corticosteroids, but a poor prognosis (47% mortality). In contrast, patients with HCV-related severe throm …
Patients with HCV-related AHA showed a higher prevalence of associated autoimmune diseases (71%), cryoglobulins (67%), and cirrhosis (59%). …
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A, Knipp S, Fox F, Strupp C, Hildebrandt B, Steidl C, Germing U, Haas R, Gattermann N. Kuendgen A, et al. Ann Hematol. 2005 Dec;84 Suppl 1:61-6. doi: 10.1007/s00277-005-0026-8. Ann Hematol. 2005. PMID: 16270213 Clinical Trial.
The response rate was 6% in refractory anemia with excess blasts (I + II), 16% in AML, and 0% in chronic myelomonocytic leukemia. Bone marrow blast count was the only variable that predicted responses. We conclude that VPA is clinically useful in low-risk MDS. ...
The response rate was 6% in refractory anemia with excess blasts (I + II), 16% in AML, and 0% in chronic myelomonocytic leukemia. Bone marro …
Does rapidly progressive iron overload in a young girl with sideroblastic anemia also signify the presence of hereditary hemochromatosis?
Scimeca PG, Weinblatt ME, Kahn E, Kochen JA. Scimeca PG, et al. Pediatr Hematol Oncol. 1994 Jan-Feb;11(1):99-104. doi: 10.3109/08880019409141906. Pediatr Hematol Oncol. 1994. PMID: 8155505
Sideroblastic anemia and iron overload in childhood are reviewed, and a pathophysiologic mechanism for the patient's clinical course is postulated....
Sideroblastic anemia and iron overload in childhood are reviewed, and a pathophysiologic mechanism for the patient's clinical course …
11 results